全球過敏診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計過敏診斷市場將從 2025 年的 64.1 億美元成長到 2034 年的 171.9 億美元，2026 年至 2034 年的複合年成長率為 11.58%。

隨著全球過敏性疾病的增加，全球過敏診斷市場正穩定成長。都市化和日益嚴重的環境污染加劇了過敏症的發生率。人們對診斷檢測的認知不斷提高，以及檢測管道的改善，顯著推動了市場擴張，而醫療基礎設施的擴張也進一步增強了市場需求。

關鍵成長要素包括體外診斷技術和就地檢驗解決方案的進步。早期檢測有助於制定更有效的治療方案和管理。兒童和老年人口的成長也促使檢測需求增加。此外，醫療保健支出的增加也推動了開發中國家對檢測技術的採用。

隨著個人化醫療的日益普及，市場前景依然光明。多重檢測平台的發展將提高效率和準確性。加大對過敏預防的宣傳力道也將提升診斷率。在醫療技術進步的推動下，市場預計將持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球過敏診斷市場：按類型分類

• 市場分析、洞察與預測
• 消耗品
• 裝置
• 服務

第5章 全球過敏診斷市場：依檢測類型分類

• 市場分析、洞察與預測
• 體內試驗
• 體外檢查

第6章 全球過敏診斷市場：依過敏原分類

• 市場分析、洞察與預測
• 吸入性過敏原
• 食物過敏原
• 藥物過敏原
• 其他過敏原

第7章 全球過敏診斷市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院檢查室和診所
• 診斷檢查室
• 學術研究機構

第8章 全球過敏診斷市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 亞太其他地區
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • Siemens Healthineers AG
  • Danaher
  • Canon Inc
  • Minaris Medical America Inc
  • Eurofins Scientific
  • Euroimmun Medizinische Labordiagnostika Ag
  • BioMAfA（C）Rieux SA
  • Stallergenes Greer Ltd
  • HollisterStier Allergy
  • Omega Diagnostics Group PLC

The Allergy Diagnostics Market size is expected to reach USD 17.19 Billion in 2034 from USD 6.41 Billion (2025) growing at a CAGR of 11.58% during 2026-2034.

The Global Allergy Diagnostics market has witnessed steady growth due to rising prevalence of allergic conditions worldwide. Increasing urbanization and environmental pollution have contributed to higher allergy incidence. Improved awareness and access to diagnostic testing have significantly supported market expansion. Growing healthcare infrastructure further strengthens demand.

Key growth drivers include advancements in in vitro diagnostic technologies and point-of-care testing solutions. Early detection enables effective treatment planning and management. Rising pediatric and geriatric populations also contribute to increased testing demand. Additionally, expanding healthcare expenditure supports adoption in developing economies.

Future prospects remain promising as personalized medicine gains traction. Development of multiplex testing platforms will enhance efficiency and accuracy. Growing awareness campaigns about allergy prevention will boost diagnostic rates. The market is expected to experience consistent growth driven by healthcare advancements.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Consumables
• Instruments
• Services

By Test Type

• In Vivo Tests
• In Vitro Tests

By Allergen

• Inhaled Allergens
• Food Allergens
• Drug Allergens
• Other Allergens

By End User

• Hospitals-Based Laboratories & Clinics
• Diagnostic Laboratories
• Academic Research Institutes

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Siemens Healthineers AG, Danaher, Canon Inc, Minaris Medical America Inc, Eurofins Scientific, Euroimmun Medizinische Labordiagnostika Ag, bioMrieux SA, Stallergenes Greer Ltd, HollisterStier Allergy, Omega Diagnostics Group PLC
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ALLERGY DIAGNOSTICS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ALLERGY DIAGNOSTICS MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. In Vivo Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. In Vitro Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ALLERGY DIAGNOSTICS MARKET: BY ALLERGEN 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Allergen
• 6.2. Inhaled Allergens Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Food Allergens Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Drug Allergens Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other Allergens Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ALLERGY DIAGNOSTICS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals-Based Laboratories & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Academic Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ALLERGY DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Test Type
  • 8.2.3 By Allergen
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Test Type
  • 8.3.3 By Allergen
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Test Type
  • 8.4.3 By Allergen
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Test Type
  • 8.5.3 By Allergen
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Test Type
  • 8.6.3 By Allergen
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL ALLERGY DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 Siemens Healthineers AG
  • 10.2.3 Danaher
  • 10.2.4 Canon Inc
  • 10.2.5 Minaris Medical America Inc
  • 10.2.6 Eurofins Scientific
  • 10.2.7 Euroimmun Medizinische Labordiagnostika Ag
  • 10.2.8 BioMAfA(C)Rieux SA
  • 10.2.9 Stallergenes Greer Ltd
  • 10.2.10 HollisterStier Allergy
  • 10.2.11 Omega Diagnostics Group PLC